Optimizing the Efficacy of First-Line Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer

被引：0
|
作者：
Shaotang Li
Pan Dr Chi
机构：
[1] Fujian Medical University,Postgraduate School
[2] Affiliated Union Hospital of Fujian Medical University,Department of Colorectal and Anal Surgery
来源：
BioDrugs | 2011年 / 25卷
关键词：
Overall Survival; Bevacizumab; Irinotecan; Oxaliplatin; Capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：43 / 50
页数：7
相关论文
共 50 条
  • [41] FOLFOXIRI PLUS BEVACIZUMAB AS FIRST-LINE TREATMENT OF BRAF MUTANT METASTATIC COLORECTAL CANCER PATIENTS
    Salvatore, Lisa
    Loupakis, Fotios
    Cremolini, Chiara
    Schirripa, Marta
    Masi, Gianluca
    Antoniotti, Carlotta
    Fornaro, Lorenzo
    Sensi, Elisa
    Lupi, Cristiana
    Bergamo, Francesca
    Lonardi, Sara
    Zagonel, Vittorina
    Fontanini, Gabriella
    Falcone, Alfredo
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 93 - 93
  • [42] Optimal Use of FOLFOXIRI Plus Bevacizumab as First-Line Systemic Treatment in Metastatic Colorectal Cancer
    Khatib, Jude
    Kainthla, Radhika
    [J]. CURRENT COLORECTAL CANCER REPORTS, 2020, 16 (04) : 89 - 95
  • [43] First-line Bevacizumab Plus Taxane-based Chemotherapy for Metastatic Breast Cancer (mBC)
    Bazan, F.
    Dobi, E.
    Villanueva, C.
    Nerich, V.
    Compagnat, F.
    Thiery-Vuillemin, A.
    Chaigneau, L.
    Nguyen, T.
    Limat, S.
    Pivot, X.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S345 - S345
  • [44] Patients with Metastatic Colorectal Cancer and Hyperbilirubinemia Treated with FOLFIRI plus Bevacizumab as First-Line Treatment
    Huang, Ching-Wen
    Yeh, Yung-Sung
    Ma, Cheng-Jen
    Tsai, Hsiang-Lin
    Chen, Chao-Wen
    Huang, Ming-Yii
    Lu, Chien-Yu
    Wu, Jeng-Yih
    Wang, Jaw Yuan
    [J]. CHEMOTHERAPY, 2017, 62 (01) : 80 - 84
  • [45] Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view
    Bencsikova, Beatrix
    Bortlicek, Zbynek
    Halamkova, Jana
    Ostrizkova, Lenka
    Kiss, Igor
    Melichar, Bohuslav
    Pavlik, Tomas
    Dusek, Ladislav
    Valik, Dalibor
    Vyzula, Rostislav
    Zdrazilova-Dubska, Lenka
    [J]. BMC GASTROENTEROLOGY, 2015, 15
  • [46] Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials
    Chen, Yan-xian
    Yang, Qiong
    Kuang, Jun-jie
    Chen, Shi-yu
    Wei, Ying
    Jiang, Zhi-min
    Xie, De-rong
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [47] Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view
    Beatrix Bencsikova
    Zbynek Bortlicek
    Jana Halamkova
    Lenka Ostrizkova
    Igor Kiss
    Bohuslav Melichar
    Tomas Pavlik
    Ladislav Dusek
    Dalibor Valik
    Rostislav Vyzula
    Lenka Zdrazilova-Dubska
    [J]. BMC Gastroenterology, 15
  • [48] Efficacy of bevacizumab in combination with doublet chemotherapy as first-line therapy in metastatic colorectal cancer according to KRAS status.
    Murai, Katsuyuki
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Hamauchi, Satoshi
    Sugiyama, Keiji
    Tsushima, Takahiro
    Mitani, Seiichiro
    Todaka, Akiko
    Honda, Kazunori
    Yokota, Tomoya
    Narita, Yukiya
    Machida, Nozomu
    Kadowaki, Shigenori
    Fukutomi, Akira
    Ura, Takashi
    Onozawa, Yusuke
    Ando, Masashi
    Yasui, Hirofumi
    Muro, Kei
    Yamazaki, Kentaro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [49] Cost-effectiveness analysis of the addition of bevacizumab to first-line chemotherapy in metastatic colorectal cancer
    Villa, D.
    Hedden, L.
    Peacock, S.
    Kennecke, H. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Bevacizumab in combination with first-line chemotherapy in patients with metastatic colorectal cancer: a meta-analysis
    Hu, W.
    Xu, W. -S.
    Liao, X. -F.
    He, H. -J.
    [J]. MINERVA CHIRURGICA, 2015, 70 (06) : 451 - 458
12345